On Wednesday, Following Stocks were among the “Top Priority Stocks” For Traders – Teradyne, (NYSE:TER), Taiwan Semiconductor Mfg. Co. (ADR) (NYSE:TSM), Neuralstem, (NYSEMKT:CUR)
Teradyne, Inc. (NYSE:TER) decreased -5.52%, and closed at $18.81. The company holds the market capitalization of $4.34B. For the last twelve months, the stock was able to keep return on equity at 3.90%, while return on assets at 3.20%, in response to its return on investment at 4.00%. Its 20-day moving average decreased -3.73%, below 50-day moving average of -1.76%, below 200-day moving average of -1.68% from the latest market price of $18.81. The mean recommendation of analysts for this stock is 2.10. (Where 1=Buy, 5=Sale).
Teradyne, Inc. (TER) provides automatic test equipment worldwide. The companys Semiconductor Test segment designs, manufactures, sells, and supports semiconductor test products and services for wafer level and device package testing in automotive, industrial, communications, consumer, computer and electronic game applications, and others. This segment offers FLEX test platform systems; Magnum test platform that tests memory devices, such as flash memory and dynamic random access memory; J750 test system to address the highest volume semiconductor devices; and ETS platform for use by semiconductor manufacturers, and assembly and test subcontractors in the low pin count analog/mixed signal discrete markets.
Taiwan Semiconductor Mfg. Co. Ltd. (ADR) (NYSE:TSM) shares picked down -5.39%, and closed at $23.18. The stock volatility for the week is 2.15%, while for the month remained 1.73%. The company holds consensus target price of $24.04.
If we consider EPS growth of the company, then the company indicated the following observations:
The company showed 1.21 diluted EPS growth for trailing twelve months. However, YTD EPS growth remained 18.60% and Annual EPS growth for the past 5 years is considered as 18.10%.
The mean recommendation of analysts for this stock is 2.40. (Where 1=Buy, 5=Sale).
Taiwan Semiconductor Mfg. Co. Ltd. (ADR) (NYSE:TSM) Limited engages in the computer-aided design, manufacture, packaging, testing, sale, and marketing of integrated circuits and other semiconductor devices. The company is also involved in researching, developing, designing, manufacturing, and selling renewable energy and saving related technologies and products; and solid state lighting devices and related applications products and systems, as well as manufactures masks.
Neuralstem, Inc. (NYSEMKT:CUR) fell -5.78%, and closed at $2.12, hitting new 52-week low of $2.12. The stock has the beta value of 1.48, and its volatility for the week is 5.81%, while for the month it is 9.61%. The company has the market capitalization of $201.83 million. The company holds the book value per share of 0.20, whereas cash per share is 0.31. Price to book ratio remained 10.60, while price to sale ratio is 10100.12. Analysts mean recommendation for the stock is said to be 2.50 (where 1=Buy, 5=sale).
Neuralstem, Inc. (CUR) a biopharmaceutical company, focuses on the development and commercialization of regenerative medicine treatments based on its human neuronal stem cells and small molecule compounds. The companys stem cell technology enables the isolation and expansion of human neural stem cells from various areas of the developing human brain and spinal cord enabling the generation of physiologically relevant human neurons of all types. Its clinical program products include NSI-566, which is in ongoing Phase II clinical trials for the treatment of amyotrophic lateral sclerosis, as well as in Phase I clinical trial for chronic spinal cord injury.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The data demonstrated in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
